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Abstract 
Ankyrins are versatile adaptor proteins that join the spectrin-based cytoskeleton to 
transmembrane proteins, and have roles in organizing the microstructure of cell membranes. 
Molecular diversity of ankyrins in mammals arises from extensive alternative splicing of the 
products of three genes. There has been no systematic analysis of the diversity of expression of 
ankyrins-G, the widely expressed Ank3 gene products, in a complex tissue. We previously 
described AnkG107, the first muscle-specific ankyrin-G. Here we combined cDNA and database 
analyses to gain novel insight into the ankyrins-G of skeletal muscle. We find: (i) that Ank3 is 
composed of at least 53 exons, many of which are subject to tissue-specific splicing; (ii) five 
novel full-length cDNAs encoding two canonical (AnkG197, AnkG217) and three small isoforms 
(AnkG109, AnkG128, AnkG130) bring to six the number of ankyrins-G expressed in skeletal muscle; 
(iii) a 76-residue C-terminal domain is a ‘signature’ for muscle ankyrins; (iv) variably spliced 
sequences of 17/18 and 195 residues increase diversity in the C-terminal domains. Comparison of 
endogenous ankyrins-G with in vitro translated cDNAs revealed that small ankyrins account for 
the majority of the immunoreactivity for ankyrin-G in soleus muscle. The small ankyrins, when 
expressed in vivo in the rat muscle, are all targeted to sarcolemmal costameres. Our results 
demonstrate the tissue-dependent alternative splicing of Ank3 in skeletal muscle and point to 
novel functions of small ankyrins-G in organizing microdomains of the plasma membrane. 
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Introduction 
Ankyrins, the versatile molecular adaptors of the spectrin-based skeleton, are responsible for 
localizing integral proteins to the appropriate membrane domains. In vertebrates, ankyrins are 
encoded by three genes, designated Ank1, Ank2 and Ank3 in rodents (ANK1, ANK2 and ANK3 in 
humans). Tissue-specific alternative splicing of transcripts results in expression of multiple 
isoforms (ankyrins-R, ankyrins-B and ankyrins-G respectively) in most tissues displaying 
different localizations and related but distinct functions. Gene knock-out experiments in mice [1-
3], siRNA depletion [4] and natural mutations in humans [5-7] demonstrate a role of ankyrins in 
organizing membrane domains and in delivering ion channels and cell adhesion proteins to the 
functionally relevant membrane sites.  
Specialized functions of ankyrins in the various tissues rely on important structural 
diversity. Ankyrins are modular polypeptides composed of highly conserved membrane-
binding (N-terminal), spectrin-binding and death domains, and a C-terminal domain that is 
variable among the three gene products. The membrane-binding domain is composed of 24 
tandem copies of 33-residue Ank-repeats which provide sites of protein-protein interaction 
in numerous proteins [8] and bind to the cytoplasmic domains of most ankyrin-associated 
integral proteins [9]. The central, spectrin-binding domain associates with β spectrins. 
Recently, the death domain of ankyrins-G has been shown to interact with the proapoptotic 
molecule Fas and to promote fas-mediated cell death in renal epithelia [10]. The divergent 
C-terminal domains are subject to extensive alternative splicing, and appear to dictate 
functional specialization of the various isoforms, including binding and targeting 
specificities. An alternatively spliced 17.3 kDa insert in the C-terminal domain of 
erythrocyte ankyrin-R modulates binding affinities for both spectrin and the anion 
exchanger [11, 12]. The ankyrin-B C-terminal domain is required for rescuing abnormal 
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inositol 1,4,5 triphosphate receptor localization in ankyrin-B(-/-) neonatal cardiomyocytes 
[13]; in these experiments, ankyrin-B and ankyrin-G C-terminal domains do not 
compensate for each other. Despite accumulating evidence pointing to the functional 
potential of C-terminal domains, presently only one interaction is known between the 
ankyrin-B C-terminal domain and a molecular chaperone, Hdj1/Hsp40 [14]. Different 
combinations of domains and the use of alternative transcription start sites generate three 
classes of ankyrin polypeptides: the canonical, Ank-repeat containing; the small, lacking all 
or part of Ank-repeats and spectrin-binding domains; the large, displaying huge insertions 
in the C-terminal domains, found so far only in the nervous system [9]. 
Alternative splicing has emerged as a major source of proteome diversity in mammals; 
according to large-scale genomics studies it may occur in 40 to 60% of human genes [15]. 
Pre-mRNA splicing combined with alternative promoter usage is a mechanism commonly 
used by components of the spectrin-based skeleton to increase functional diversity and to 
regulate cell type-specific expression [9, 16]. Elucidation of the structure and organization 
of the human ANK1 gene allowed the understanding of the complex alternative splicing 
pattern of ankyrins-R [17]. However, little is known about the other two genes, and in 
particular the broadly expressed Ank3. This gene codes for a variety of alternatively spliced 
isoforms including large [18], canonical [19, 20] and small variants [21-23] with molecular 
masses ranging from ~100 kDa to 480 kDa.  
We recently identified AnkG107, a novel small ankyrin-G from rat skeletal muscle, which 
lacks the entire Ank-repeat domain, contains a unique muscle-specific 76-residue insertion in the 
C-terminal domain and is targeted to the sarcolemma [24]. In skeletal muscle fibers, assembly of 
specialized membrane domains is a functional requirement, both at the cell surface and in the 
cytoplasm where Ca2+-regulated excitation-contraction coupling occurs. Ankyrins-B have been 
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lately implicated in human heart disease due to abnormal coordination of multiple functionally 
related ion channels and transporters [5, 7]. Multiple ankyrins are expressed in skeletal muscle 
fibers by all three genes [2, 21, 25-28] and localize to the postsynaptic membrane [29, 30], the 
costameres [3, 31, 32], the triads and the non junctional sarcoplasmic reticulum [27, 28, 33]. A 
muscle-specific promoter gives rise to sAnk1, a truncated ankyrin-R which is thought to link the 
sarcoplasmic reticulum to myofibrils [27, 34, 35]. To understand the complex functions of 
ankyrins in muscle cells, we sought to establish the tissue-specific expression of muscle ankyrins-
G. Here we report five novel ankyrins-G including canonical and small variants. Annotation of 
their full length cDNAs together with all so far described ankyrin-G sequences to the rat Ank3 
gene led to the demonstration of a muscle-specific alternative splicing pattern. Moreover, the 
small isoforms appear to represent the majority of ankyrins-G in skeletal muscle and they are 
targeted to sarcolemmal costameres despite the lack of Ank-repeats. 
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Materials and methods 
Isolation of cDNA clones 
A rat skeletal muscle λgt10 cDNA library (Clontech) was screened with two Ank3 cDNA 
fragments derived by PCR (polymerase chain reaction) amplification from 270-kDa ankyrin-G 
(GenBank Accession no. AF102552) membrane-binding (bp 1481-2381) and C-terminal (bp 
6999-7867) domains. The probes were labelled with [α-32P]dCTP using a random primer 
labelling kit (Stratagene). Plaque-lifted filters (Nytran Plus; Schleicher & Schuell) were 
hybridized overnight in hybridization buffer containing 6X SSC (1X SSC: 0.15 M NaCl, 0.015 M 
sodium citrate, pH 7.0), 5X Denhardt’s, 0.2% SDS, and 50 µg/ml sonicated salmon sperm at 
65°C. The filters were washed at a maximum stringency 0.2X SSC, 0.1% SDS at 65°C. The 
positive phage clones were plaque purified via three rounds of screening. Phage DNA from 
selected clonal isolates was either extracted from plate lysates by standard methods (Qiagen 
Lambda Kit; Qiagen) or amplified by PCR  using primers flanking the insert sequences (gt1, gt2; 
see Table1) and a high-fidelity polymerase mix (Advantage; Clontech). Restricted cDNA inserts 
were gel purified (Qiaquick Gel Extraction Kit; Qiagen) and subcloned into pUC18 vector 
(Qbiogene). DNA sequence determination was performed by MWG, Germany. The full length 
cDNAs not included in these phages were obtained by nested PCR amplifications using 0.5 ng of 
rat skeletal muscle cDNA (Marathon-Ready; Clontech) as a template,  two pairs of untranslated 
region (UTR)-based primers (Table 1), and a high-fidelity polymerase mix (Advantage 2; 
Clontech). The primer combinations for the long isoforms were 5’UTRmb-ne1 and 13/2-1R for 
the first round, and 5’UTRmb-ne2 and 3’UTRn2 for the second round of PCR; the primer 
combinations for the short isoforms were 5’Malpa and 13/2-1R for the first round, and Malpan2 
and 3’UTRn2 for the second round of PCR. PCR products were subcloned into the TOPO-
pCR2.1 vector (Invitrogen). Clones were analyzed by standard colony PCR methods to 
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distinguish between cDNA inserts of different size and composition. DNA from selected clones 
was extracted by standard methods (Qiagen Plasmid Midi Kit; Qiagen) and sequenced.  
Rapid amplification of cDNA ends (RACE) analysis 
The 5’ and 3’ ends of the Ank3 transcripts were determined using Marathon-Ready rat 
skeletal muscle cDNA (RACE system; Clontech). 5’ and 3’ RACE was performed following the 
recommended protocol except that the second PCR reactions were carried out with 1/100 of the 
material from the first reaction as a template. The gene-specific primers were as follows (Table 
1). 5’ RACE:  5’RACEn3 and 3’Malpa (initial PCR reactions), and 5’RACEn4 and 3’Malpan2 
(nested PCR reactions) for the long and short isoforms respectively; 3’ RACE: 9/3-1 (initial PCR 
reactions), and either 17Aup or 9/3-2 (nested PCR reactions). The amplified fragments were 
subcloned into the TOPO-pCR2.1 vector (Invitrogen) and sequenced. 
Bioinformatics 
Routine sequence analysis of the nucleotide and protein sequences was performed using 
the LASERGENE software package (DNASTAR). Cloned muscle ankyrin-G cDNAs were used 
for querying the NCBI BLAST server. Sequences from 
various rat Ank3 transcripts were extracted from the non-redundant (nr) DNA database. To 
determine the chromosomal location of the Ank3 gene a BLAT query (genome.ucsc.edu) of 
the rat genome was performed using cloned (this paper) and database-derived ankyrin-G cDNA 
sequences. The genomic sequence corresponding to the Ank3 gene plus ~180 kb extensions at 
both ends was extracted from the Ensembl database (Ensembl Rat release 14.2.1; 
www.ensembl.org/Rattus_norvegicus). Transcribed cDNA sequence data were aligned to 
the genomic Ank3 sequence using the EMBOSS program est2genome 
(www.hgmp.mrc.ac.uk/Software/EMBOSS/). The textual outputs of est2genome were 
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graphically displayed and processed with the genome annotation tool Artemis release 5.0 
(www.sanger.ac.uk/Software/Artemis/v5/). In all cases predicted matches and the presence 
of canonical splicing sites (GT/AG) was confirmed by eye. Poly-A sites in the genomic sequence 
were predicted using the program polyadq (argon.cshl.org/tabaska/polyadq_form.html) 
analyzing both canonical poly-A patterns AATAAA and ATTAAA. Rat expressed sequence tags 
(EST) sequences were identified by querying the Gene2EST BLAST Server (woody.embl-
heidelberg.de/gene2est/) with the Ank3 genomic sequence. Database-derived protein sequences of 
human and murine ankyrins-G were annotated to the rat Ank3 gene using the program Wise2 
(www.ebi.ac.uk/Wise2/).
Isolation of genomic clones  
The genomic region containing the novel muscle Ank3 exon 25 not present in the Ensembl 
database was amplified by PCR from rat genomic DNA (Clontech) using exon-based primers 
e24u and e26r1 (Table1) and a high-fidelity polymerase mix (Elongase Amplification System; 
Invitrogen) according to the manufacturer’s recommendations. Cycling conditions were as 
following: 94 °C for 1 min; 8 cycles of  15 s at 94 °C and 10 min at 72 °C decreasing 0.5 °C per 
cycle; 27 cycles of 15 s at 94°C and 10 min at 68 °C; final extension at 68 °C for 15 min. The 
amplified fragment was subcloned into the TOPO-pCR2.1 vector (Invitrogen) and sequenced.  
In vitro expression and immunoblot analyses 
Coupled in vitro transcription and translation analyses were carried out employing a rabbit 
reticulocyte based T7 expression kit (Promega) according to the manufacturer’s protocol. PCR-
amplified cDNAs encoding all small muscle ankyrin-G isoforms previously subcloned via an 
EcoRI site into pcDNA3 vector (Invitrogen) were used. Products were resolved by SDS PAGE 
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electrophoresis and revealed by western blot analysis using polyclonal antibodies against the 
76aa insert [24]. In control experiments for both the reaction and the specificity of the antibody, 
in vitro translation was performed with cDNAs encoding anti-sense AnkG107 and AnkG107 lacking 
the 76aa insert (AnkG107∆76aa). Both controls were negative. 
Northern Blot Analysis 
Rat poly(A)+ RNA multiple tissue Northern blots (Clontech, Origene) were consecutively 
hybridized with cDNA probes corresponding to epithelial insert C (AnkG128, bp 2212-2703) and 
specrtrin-binding domain (AnkG128, bp 68-988) sequences of rat muscle ankyrins-G. The probes 
were labeled with [α-32P]dCTP using a random primer labeling kit (Stratagene) and purified by 
standard chromatography methods. Hybridizations were carried out according to the 
manufacturer’s recommendations using ExpressHyb solution (Clontech). The membranes were 
washed at a maximum stringency of 0.1XSSC, 0.1% SDS, 50°C prior to autoradiography.  
In vivo DNA injection and immunofluorescence confocal microscopy  
Direct gene transfer experiments into rat muscles were performed as described [36, 37]. Briefly, 
pEGFP-N1 plasmids containing full length cDNAs for the small muscle ankyrins-G were diluted 
to a final concentration of 1-2 mg/ml in a 20% sucrose / 0.5x PBS (10 mM phosphate buffer, 150 
mM NaCl, pH 7.4) solution. For each isoform, about 40 µl of DNA solution were injected into 
12-day old rat anterior tibialis muscles in vivo.  As a control, the vector without ankyrin-coding 
sequences was used. Two independent injection experiments per isoform were performed using 
rats from different liters. Ten days after injection, muscles were removed, fixed with 3% 
paraformaldehyde / 0.1 M phosphate buffer pH 7.4 for 1h at 4°C, cryoprotected with 0.7 M 
sucrose and frozen in liquid nitrogen-cooled isopentane. Cryostat 10 µm-thick sections of muscle 
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fibers expressing the fusion proteins were selected by direct GFP fluorescence and double-
labeled for indirect immunofluorescence with primary antibodies diluted at 2-5 µg/ml as 
previously described [28]. Monoclonal antibodies to the green fluorescent protein (GFP) were 
from Sigma. Polyclonal antibodies to αΙΙ-spectrin were previously described [38] and were a 
generous gift from Dr. M. C. Lecomte (INTS, Paris). FITC- and Cy3-conjugated secondary 
antibodies were from Jackson Immunoresearch Laboratories (West Grove, PA). Confocal laser 
scanning microscopy was performed using a TCS-4D confocal imaging system (Leica 
instrument), equipped with a 63x objective (plan apo; numerical aperture = 1.32). For FITC and 
CY3 excitation, an Argon-Krypton ion laser adjusted at 488 and 568 nm, respectively, was used. 
The confocal system was adjusted to allow field depths of ~0.5 µm. Digital images were captured 
using MetaView Imaging System (Universal Imaging Corp.) and arranged using Adobe 
PhotoShop. Animal experiments were carried out according to relevant ethical protocols. 
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Results 
Isolation and characterization of rat skeletal muscle ankyrin-G cDNAs 
We previously reported the expression of multiple ankyrin-G isoforms in skeletal muscle, 
based on the detection of two clusters of 8 kb and 5.6 kb Ank3 transcripts [24]. Northern blot 
analysis using domain-specific probes strongly suggested the presence of two types of ankyrins, 
the canonical Ank-repeat-containing, and the small variants. Only one small isoforms, AnkG107, 
had been cloned so far. To isolate a broad range of ankyrins-G including the hypothetical 
canonical isoforms, a rat skeletal muscle cDNA library (Clontech) was screened with probes 
corresponding to the generic ankyrin-G C-terminal domain and to Ank-repeats (Figure 1A). 
Two out of twelve independent clones contained Ank-repeats and covered sequences 
ranging from 5’UTR to the beginning of the spectrin-binding domain. Coding sequence begun 
with exon 1e previously described for epithelial and brain canonical ankyrins-G [2]. Three 
clones, including one full-length clone, covered a different 5’UTR and 5’ coding sequence 
starting with amino acids MALPHS previously found in AnkG107 [24] and in the murine epithelial 
Ank3-5kb [19], and followed by the spectrin-binding domain. These results confirmed the 
presence of canonical and small ankyrins-G in skeletal muscle. Clones covering 3’coding and 3’ 
UTR sequences contained two additional inserts as compared to AnkG107: a 195-residue sequence 
originally described in epithelial ankyrins-G from kidney [19], and a novel 17/18-residue insert 
(17/18 aa) preceding the muscle-specific 76 aa stretch (Figure 1B and Supplementary Figure 1).   
In order to determine 5’ and 3’ ends of muscle Ank3 transcripts and to investigate further 
sequence variations we performed RACEs employing different pairs of nested primers (Table 1) 
and rat muscle Marathon-Ready cDNA as a template. 5’RACE for both canonical and small 
ankyrins-G resulted in cDNAs differing only in the length of their 5’ UTRs (Supplementary 
Figure 2). No alternative 5´ coding sequence was identified. 3’ RACE was performed with 
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primers corresponding either to sequences shared by all muscle transcripts, or to the 17/18 aa 
insert. Four types of cDNAs were isolated showing identical coding and UTR sequences differing 
only in their length beyond the stop codon.  
To define the exact combinations of 5’ and 3’ sequences of each isoform, full length 
cDNAs were obtained by PCR using rat skeletal muscle Marathon-Ready cDNA (Clontech) as a 
template. Six muscle ankyrin-G isoforms were identified (Figure 1A) including AnkG107. By 
analogy with AnkG107, we termed the five novel isoforms according to their calculated molecular 
weight AnkG109 (ORF of 2571 bp), AnkG128 (ORF of 3471 bp), AnkG130 (ORF of 3522 bp), 
AnkG197 (ORF of 5421 bp), and AnkG217 (ORF of 5955 bp).  
Previous studies [24] reported that the primary sequence of the first muscle isoform 
AnkG107 differed from homologous Ank3 gene products isolated from other tissues at three major 
points: 1) residues PKI replace residues LRSF within the spectrin-binding domain (aa 48-50); 2) 
a deletion of 12 residues occurs in the end of the spectrin-binding domain at position aa 590; 3) a 
76-residue insert (aa  864-939) is present near the COOH terminus (Figure 1A, AnkG107: a, b and 
c, respectively). Sequence analysis of the five novel muscle isoforms showed that these features 
are common to all six muscle ankyrins-G (Figure 1A), strongly suggesting tissue-specific 
alternative splicing events. We refer to these features as muscle-specific signatures for ankyrins-
G. 
Sequence differences between the six isoforms occur in the N-terminal region (presence 
or absence of the 24 membrane-binding Ank-repeats), and in the C-terminal domain due to the 
195 aa and 17/18 aa inserts. Sequence analysis of the muscle 195 aa revealed 88% identity on the 
protein level when compared to its murine homolog insert C in 7kb-Ank3 and 5kb-Ank3 kidney 
ankyrins-G (GenBank Accession no. AAB01607 and AAB01603, respectively). The difference 
between 17 aa and 18 aa is due to the additional N-terminal residue Gln (Figure 1B). Database 
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searches against the 17/18 aa yielded only one relevant hit, an EST clone from pooled human 
uterus adenocarcinoma (GenBank Accession no. AW439255). Canonical ankyrins contain either 
the 195 aa or the 18 aa inserts, whereas the small isoforms showed all four possible combinations 
with 17 aa and 195 aa either alternatively present, both missing (AnkG107), or, in a single case, 
both present in the C-terminal domain. Another isolated case showed the presence of the 18 aa in 
a small isoform.   
Annotation of cDNA sequences to the Ank3 locus  
To determine exon usage and alternative splicing events leading to the muscle-specific 
expression of ankyrins-G, we examined the organization of the rat Ank3 gene. A database search 
of rat genomic sequences employing all available sequence data of rat Ank3 transcripts revealed 
that the Ank3 gene spans a region of over 600 kb on rat chromosome 20p11. The genomic 
sequence assembly covering the Ank3 locus was downloaded from the Ensembl database. 
Whenever necessary, we refined this genomic contig by additional cloning and sequence analysis 
to exclude any uncertainties caused by sequencing gaps.  
The exon-intron structure was established by annotating our full length and RACE clones 
as well as previously cloned rat epithelial AnkG190 [20] and rat neuronal 270 kDa ankyrin-G [18] 
to the rat genomic sequence (Figure 2). Considering only rat ankyrin-G sequences our analysis 
identified 53 exons. Exons found in muscle transcripts were numbered 1 to 47 while non-muscle 
exons were indicated by roman numbers. All splice junctions displayed the canonical GT/AG 
dinucleotides. The complete list of exon/intron boundaries is available as supplementary data. 
The overall organization of the exons shed light on a complex pattern of alternative splicing. In 
addition to the two distinct first exons of muscle isoforms (exon 1 and 23), we annotated the two 
first alternative exons used by AnkG190 (exon I followed by exon II) and 270 kDa ankyrin-G 
(exon III). Exons 2 to 22 encod the 24 Ank-repeats; a 24 bp exon IV was only found in 270 kDa 
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ankyrin-G. Interestingly, muscle isoforms contain neither insert A nor insert B at the end of the 
membrane-binding domain previously identified in the mouse epithelial Ank3-7kb [19]; insert A 
(Figure 2, exon V) is present in both non-muscle AnkG190 and 270 kDa    ankyrin-G.  
The spectrin-binding domain is encoded by exons 24 to 36. The muscle-specific sequence 
PKI is encoded by a single exon of 12 bp (exon 25). Identification of this exon required cloning 
of the corresponding genomic sequence (Figure 3A) not yet present in the latest Ensembl Rat 
assembly 3 (v28.3e.1; February 3rd, 2005). Exon 26 contains an internal splice acceptor site used 
by all muscle transcripts. Part “a” of exon 26 (Figure 3B) encodes amino acids LRSF spliced out 
in muscle transcripts, and does not appear as an independent exon because of the lack of a splice 
donor site. In the end of the spectrin-binding domain, an internal splice donor in exon 36 causes 
the deletion of 12 residues observed in muscle isoforms. Part “a” of exon 36 lacks the acceptor 
splice site and consequently adjacent part “36b” does not appear as a distinct exon (Figure 2). 
Between exons 36 and 37, a single exon VI, present in rat 270 kDa ankyrin-G, encodes 
the Ser/Thr rich sequence previously identified in neuronal ankyrins-G. These isoforms 
specifically localize at the nodes of Ranvier and initial axonal segments [18]. All so far muscle 
transcripts identified have this exon spliced out.  
The C-terminal domain is encoded by exons 37 to 46. The conserved death domain 
sequences as defined by databases Pfam [39] (amino acids DIRMA…LEGPI) and SMART [40] 
(PQSPC… LEGPI) are present in all muscle isoforms. Exon 40 shows an internal splice acceptor 
site giving rise to transcripts containing part “b” either alone or in combination with part “a” 
(Figure 2). Part “a” encodes the entire 195 aa insert. Both variants have been found in muscle 
(this paper) and kidney [19]. The muscle-specific 76 aa insert is encoded by exactly three 
contiguous exons 43 to 45. Preceding exon 42 encodes the novel 17/18 aa segment. An internal 
splice donor site is responsible for the absence of the N-terminal Gln that distinguishes insert 18 
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aa from 17 aa. Interestingly, genomic sequence comparison revealed that rat exon 42 is highly 
conserved when compared to corresponding mouse, chimpanzee, and human sequence (96%, 
81%, and 80% identity); however, in humans and chimpanzee only the 17 aa version is expressed 
due to a base exchange within the first acceptor splice site (data not shown). Exon 46 harbours 
the translation stop codon and 20 bp of 3’UTR sequence. Interestingly a second stop codon is 
found contiguous to the first one. 
Further 3’UTR sequence is encoded by exon 47. This exon contains two “AATAAA” and 
one "ATTAAA" polyA signals 532 bp, 596 bp and 943 bp downstream of the first stop codon 
(Figure 2). 3’RACE clones extended beyond all three polyA signals. The longest clone ended 
1070 bp downstream of the stop codon. Interestingly, all cDNAs terminated in A-rich sequences 
which were confirmed by comparison with the genomic sequence and could be the reason for 
annealing of oligo-d(T) primers during the first-strand cDNA synthesis. Several additional 
putative polyA signals were observed in the genomic region proximal to aligning 3’ RACE 
sequences; the most likely to be a real poly-A site (70% probability) was found 1558 bp 
downstream of the stop codon. Two rat EST clones (GenBank Accession no. AA892174, kidney, 
and BE116901, whole embryo) extended our 3’RACE results and confirmed the usage of the 
predicted poly-A site (data not shown).   
To extend insights into exon usage and splice patterns of muscle ankyrins-G, we 
performed a Gene2EST BLAST search of the rodent EST database employing the genomic rat 
Ank3 sequence. EST sequences revealed no additional splice variants of muscle ankyrins-G.  
Further information on the gene structure was obtained by annotating all isoforms so far isolated 
from other species to the rat Ank3 gene using the Wise2 program. Analysis of homologous 
sequences of human brain 480-kDa ankyrin-G (GenBank Accession no. AAA64834), human 
Golgi AnkG119 (AAB08437), mouse macrophage ankyrin-3 (AAB58381), mouse skin ank3-93 
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(AF212924), mouse epithelial Ank3-5kb (AAB01603) and Ank3-7kb (AAB01607) showed that 
the overall exon structure and splice sites are highly conserved.   
Additional residues ETESDQDDE present only in the spectrin-binding domain of human 
480-kDa ankyrin-G [18] corresponded to an individual exon between exons 35 and 36. Inserts A 
and B of epithelial ankyrins-G [19] are encoded by two individual exons. The huge 2604 aa tail 
domain of 480-kDa ankyrin-G is encoded by a single exon. Alternative splicing of this exon 
gives rise to the 850 aa tail domain of rat 270 kDa ankyrin-G (Figure 2, exon VI). The smaller 
known ankyrin-G is the skin-specific isoform ank-393 [23] which lacks Ank-repeats and the first 
75 residues of the spectrin-binding domain. Our analysis revealed that this variant results from 
alternative splicing joining rat exon 1 to exon 27.  
Tissue expression of muscle ankyrin-G isoforms 
Northern blot analysis was carried out to assess the tissue expression of ankyrins-G 
containing the novel inserts. High stringency hybridization of poly(A+)RNAs from several rat 
tissues was carried out with cDNAs corresponding to the195 aa insert (Figure 4A) and to the 
spectrin-binding domain (Figure 4B). These experiments showed that: 1) the tissue expression 
pattern of 195 aa-containing isoforms was comparable to the general pattern of ankyrins-G, with 
195 aa-positive transcripts more abundant in heart, skin and testis, and 2) the relative 
hybridization signals of the two probes were different, suggesting that the expression of 195 aa-
containing ankyrins-G varies among tissues with maximum relative levels in skin and reduced 
levels in kidney, brain, and testis. Skeletal muscle transcripts containing 195 aa corresponded to 
both 8 kb and 5.6 kb clusters of messages [24] (Figure 4C). Our attempts to get information on 
the tissue expression pattern of the 17/18 aa-containing isoforms using different oligonucleotide 
probes were not conclusive.  
We further compared the electrophoretic mobility of in vitro translated small isoforms 
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AnkG107, AnkG109, AnkG128 and AnkG130, with endogenous ankyrins-G in 18-day-old rat skeletal 
muscle homogenates (Figure 5). Western blot analysis using anti-ankG76aa antibodies showed 
that the two endogenous polypeptides of 190 kDa and 130 kDa [24] co-migrated with isoforms 
either containing or not the 195 aa insert, respectively. The presence of the 17 aa insert did not 
significantly alter migration in this gel system. These results confirmed that the cloned isoforms 
carrying the novel inserts are indeed expressed in skeletal muscle fibers. 
Intracellular targeting of muscle ankyrin-G isoforms 
To gain insight into possible functional consequences of the different exon combinations 
of the C-terminal domains, we followed the subcellular targeting of the four small muscle 
isoforms when expressed as GFP fusion proteins in the rat skeletal muscle. cDNAs encoding 
AnkG107, Ank G109, Ank G128, and Ank G130 were injected in vivo into the tibialis anterior muscle of 
12 day-old rats and the distribution of expressed proteins was assessed ten days later on 
cryosections of injected muscles by indirect immunofluorescence and confocal microscopy 
(Figure 6). No evident differences in targeting between isoforms were observed at this level of 
analysis. All isoforms displayed a predominantly sarcolemmal distribution, as previously shown 
for AnkG107. Low levels of intracellular staining did not show distinct patterns among isoforms. 
The only difference in localization occurred upon deletion of the 76 aa insert which resulted in 
increased cytoplasmic distribution in agreement with previous observations [24]. Colocalization 
of GFP fusion proteins (Figure 6A) with αII spectrin and superficial confocal optical sections 
(Figure 6B) strongly suggested a costameric pattern of distribution. In control experiments, GFP 
alone remained in the cytoplasm.  
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Discussion 
This study provides the first insights into the organization of the Ank3 gene, and a 
systematic analysis of the diversity of ankyrin-G expression in the rat skeletal muscle. In the case 
of large genes like Ank3 undergoing extensive alternative splicing, the application of either gene 
finding programs or EST annotation alone does not yield satisfactory results [41]. On the other 
hand, cloning of partial cDNA fragments usually derived from either library screening or RT- 
PCR do not provide ultimate information on the exon composition of transcripts as expressed in 
tissues. We combined cloning of full length cDNAs and computing sequence analysis to show 
that i) the rat Ank3 gene, located on chromosome 20p11, is composed of at least 53 exons 
spanning a region of over 600 kb known to be syntenic to human chromosome 10q21[42], ii) 
these exons exhibit a complex, tissue-dependent pattern of alternative splicing, and iii) in skeletal 
muscle two alternative first exons 1 and 23 give rise to transcripts encoding canonical and small 
ankyrins-G respectively. Exon 1 is expressed in several tissues including striated muscle, brain, 
kidney and skin [2, 23]. No other first exon was found in skeletal muscle transcripts by 5’RACE 
using primers within Ank-repeats. Exon 23 has been so far reported only in kidney [19] and 
skeletal muscle [24]. Ank-393, the smaller known ankyrin-G isoform [23] or even further 
truncated variants similar to the Ank1 gene product sAnk1 [34, 35] were not detected in skeletal 
muscle by 5’RACE.  
In this study, two canonical and four small muscle ankyrins-G have been isolated and 
characterized, including the previously reported AnkG107 [24]. We termed the novel isoforms 
AnkG109, AnkG128, AnkG130, AnkG197, and AnkG217 based on their calculated molecular weight. The 
expression of these isoforms in muscle tissue was assessed by comparing the pattern of in vitro 
translated cDNAs on western blots with endogenous ankyrin-G polypeptides, as well as by 
Northern hybridization. The four small muscle isoforms comigrated with 130 kDa and 190 kDa 
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muscle polypeptides. Higher apparent molecular weight polypeptides previously reported in 
muscle lysates [24] should account for the canonical isoforms. Finally, expression of GFP fusion 
proteins in rat skeletal muscle fibers in vivo injected with cDNAs encoding the four small 
ankyrins-G showed preferentially targeting to the sarcolemma where they co-localize with 
spectrin at costameres. 
One major conclusion of this study is that common sequence features distinguish muscle 
isoforms from ankyrins-G expressed in other tissues. AnkG107, the first muscle ankyrin-G identified, 
previously revealed three unique sequence features as compared to all so far cloned ankyrins-G, 
namely the presence of residues PKI and deletion of the last 12 residues in the spectrin-binding 
domain, and the presence of the 76aa insert near the C-terminus [24]. These features were found in 
all five novel isoforms, strongly suggesting that they constitute muscle-specific "signatures" of 
ankyrins-G. The establishment of intron/exon boundaries demonstrated that all three features derive 
from alternative splicing (Figure 2). 
Diversity within muscle isoforms occurs in the C-terminal domains. We identified two 
additional inserts issued from alternative splicing, 17/18 aa and 195 aa, which do not appear to be 
muscle-specific. The 195 aa sequence is homologous to the previously described epithelial insert 
C, a highly acidic alternative sequence of the mouse ankyrin-G C-terminal domain found in 
kidney transcripts [19]. The usage of the alternative splice site giving rise to 195 aa is not limited 
to certain tissues. Isoforms with and without insert have been previously observed in kidney [19], 
skin [23] and macrophages [22]. Accordingly, our Northern blot data show that 195 aa-containing 
transcripts are present in all ankyrin-G-expressing rat tissues here analyzed, including skeletal 
muscle and heart. However, their relative expression levels as compared with total Ank3 
transcripts varied among tissues, with an important enrichment in skin and reduced levels in 
kidney, brain, and testis. The novel 17/18 aa sequence immediately preceding the 76 aa insert is 
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encoded by a single 54 bp exon. Rat multi-tissue Northern blot analysis employing two different 
oligonucleotide probes was not conclusive. Comparison between vertebrate genomic sequences 
revealed that the 17/18 aa is highly conserved (data not shown). Nevertheless, extensive database 
searches identified only one EST clone (human uterus, pooled ardenocarcinoma) and showed no 
significant homology with known proteins including products of other ankyrin genes. Taken 
together these observations suggest that the 17/18 aa sequence is specific for ankyrins-G and it is 
weakly expressed in a limited number of tissues.  
The high degree of conservation of vertebrate ankyrin-G protein sequences allowed us to 
precisely annotate all so far known isoforms to the rat genome, with three exceptions: i) sequence 
preceding the putative start codon of mouse macrophage ankyrin-3 [22] corresponds to three 
contiguous upstream exons in canonical ankyrins and therefore it is unlikely to be 5’UTR: ii) 
5’UTR and the alternative first exon of human AnkG119 [21] could not be assigned to human 
chromosome 20; iii) the unique short C-terminal and 3’UTR sequences of AnkG119 could not be 
assigned to the human genome. This approach showed that the overall exon structure and splice 
sites are highly conserved among species. Examples of tissue-dependent preferential exon usage 
include the lack of both epithelial inserts A and B from muscle isoforms and AnkG119, the only 
non-muscle isoform also lacking amino acids LRSF.  
 The here identified alternative splicing events address the functional consequences of 
structural diversity for muscle ankyrins-G. Various combinations of the two alternatively spliced 
195 aa and 17/18 aa inserts in the C-terminal domain have been found in both types, canonical 
and small isoforms. The two inserts may provide novel ligand-binding capacities by either 
creating new binding sites or influencing interactions of neighbouring domains of the protein. 
Moreover, the 76 aa insert appears as an entity encoded by three complete exons that are spliced 
out together in non muscle transcripts, and may act as a separate module or protein-protein 
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interaction domain. Interestingly, the binding sites of the muscle-specific sarcoplasmic reticulum-
associated sAnk1 isoform [27] for muscle proteins titin and obscurin [43-45] reside within the 
region of high homology with the 76 aa of muscle ankyrins-G. By analogy, the 76 aa may be 
involved in interactions with other sarcolemmic and/or cytoplasmic muscle proteins, as 
previously proposed for AnkG107 [24]. Such interactions as well as their potential modulation by 
the presence of the preceding 17/18 aa sequence remain to be established. Another interesting 
question to address will be the significance of the muscle-specific alternative sequence PKI in the 
spectrin-binding domain. Even very short alternative sequences may have major functional 
consequences, like for instance in the case of agrin, the heparan sulfate proteoglycan that 
organizes the postsynaptic differentiation of the neuromuscular junction [46].  
One consequence of sequence variability could be a differential subcellular targeting. We 
previously showed that AnkG107 is targeted to the sarcolemma when transfected in primary 
cultures of skeletal muscle cells [24]. Here we applied direct gene transfer in skeletal muscle, an 
established approach for expression studies of muscle proteins [36, 37]. We followed the 
localization of the four GFP-tagged small muscle isoforms in living cells during final maturation 
of muscle fibers. Interestingly, all isoforms were preferentially addressed to the sarcolemma 
where they displayed a costameric pattern of distribution (Figure 6). Our results directly 
demonstrate that Ank-repeats are not required for membrane localization. The spectrin-binding 
domain alone is apparently capable of addressing ankyrins to the plasma membrane, as 
previously suggested in neurons and muscle cells [24, 47].  
Costameres, the sarcolemmic structures that physically couple the force-generating 
sarcomeres to the sarcolemma and beyond, to neighbouring muscle cells via the extracellular 
matrix [48], are made of several multi-protein assemblies capable of binding actin: Na/K ATPase 
and the spectrin/ankyrin complex; integrins and the vinculin/talin/α-actinin complex; the 
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dystrophin complex. One obvious partner for ankyrins at costameres is the Na/K ATPase [20, 49-
52]. However, in skeletal muscle fibers, products of all three ankyrin genes have been localized at 
the costameres [3, 24, 28, 32]. Moreover, our targeting studies suggest that several alternatively-
spliced ankyrins-G are present at these membrane sites. Williams and colleagues [32] showed 
that an ankyrin-G isoform of apparent molecular mass 190 kDa co-localized at costameres and 
co-immunoprecipitated with Na,K-ATPase and alpha-II /beta-I spectrins of adult sarcolemma 
[53]. Data in this paper demonstrate that the small costameric isoforms lacking Ank-repeats are 
the major ankyrin-G polypeptides in skeletal muscle, they co-localize with sarcolemmal alpha-II 
spectrin at costameres, and two of them, AnkG128 and AnkG130, have apparent molecular masses 
on western blots close to 190 kDa. Responsible for their association with the sarcolemma could 
be the direct interaction of the spectrin-binding domain not only with spectrin but also with other 
sarcolemmal proteins: Interestingly, two previous studies report that, in addition to and 
independently from Ank-repeats, the spectrin-binding domain also binds to the Na,K-ATPase 
[20, 50]. Taken together these results may suggest a novel role for small ankyrins, so far 
predominantly found in intracellular sites [19, 21, 22], in organizing the costameric 
microdomains by linking the Na,K-ATPase to muscle spectrin; alternatively, they may be 
important for localizing relevant cytoplasmic proteins to these membrane sites. 
In conclusion, this study revealed important structural features of the Ank3 gene and 
elucidated the molecular basis for the complexity of ankyrin-G transcripts in skeletal muscle. 
Furthermore, the isolation of five novel ankyrin-G isoforms provides the basis for identification 
of interacting proteins and determination of the functional role(s) of ankyrins-G in the skeletal 
muscle under normal and pathogenic conditions.  
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Figure Legends 
Figure 1. (A) Schematic representation of rat skeletal muscle ankyrin-G isoforms.  
Domain organization of the five novel ankyrin-G isoforms and their comparison with brain 270 
kDa ankyrin-G and muscle AnkG107. Dotted boxes on top of 270 kDa ankyrin-G indicate the 
probes used for screening the cDNA library. The three specific sequence features distinguishing 
all muscle isoforms from non-muscle ankyrins-G are indicated as follows: presence of residues 
PKI (a), lack of a 12-residue stretch at the end of the spectrin-binding domain (b), and presence 
of the 76 residue insert in the C-terminal domain (c). Ankyrins are named according to their 
predicted molecular weight. 
(B) Sequence of the novel 17/18aa insert of the C-terminal domain.  
 
Figure 2. Genomic organization of rat Ank3 sequences.  
The exon/intron structures were determined by comparing sequences of rat cDNAs with the 
genome. Exons are represented by closed boxes and numbered consecutively below (arabic 
numbers: exons found in muscle transcripts; roman numbers: non-muscle exons). Untranslated 
sequences are shown in white and coding sequences in black (muscle) or grey (non-muscle). 
Alternative splicing within exons is indicated by letters (a,b). Asterisks indicate polyadenylation 
signals. Introns are not drawn to scale.  
 
Figure 3. Sequence (A) and in scale schematic representation (B) of the genomic region 
surrounding muscle specific exon 25.  
Exon sequences are shown in capital or in lowercase (not present in muscle transcripts) letters, 
intron sequences are in italic, lowercase letters. Written in boldface is the sequence of exon 25. 
Dinucleotides of splice acceptor/donor sites are underlined. PCR primers are underscored with 
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arrows. Closed boxes represent muscle (in black) and non-muscle (in grey) coding sequences. 
Splicing patterns of muscle (solid line) and non-muscle (dotted line) transcripts are shown.  
 
Figure 4. Tissue expression of Ank3 transcripts.  
A rat multiple tissue Northern blot (Origene) was consecutively hybridzed with cDNA probes 
corresponding to the 195 aa insert (A) and derived from the spectrin-binding domain shared by 
all ankyrins-G (B). The expression pattern of 195 aa-containing transcripts in kidney, skeletal 
muscle, and heart is shown in (C), (Clontech, rat multiple tissue Northern blot). Lower panel 
shows hybridization with control beta actin probe.  
 
Figure 5. In vitro transcription/translation of full-length cDNAs encoding the small muscle 
ankyrins-G.  
cDNAs were cloned in pcDNA3. Products of in vitro transcription/translation were resolved by 
SDS PAGE, revealed by western blot analysis using the anti-ankG76aa antibody, and compared to 
endogenous immunoreactive polypeptides in 18 days-old total rat soleus muscle lysates. As a 
control, AnkG107 lacking the 76aa insert (AnkG107∆76aa), was not revealed by this antibody. 
 
Figure 6. Subcellular targeting of the small muscle ankyrins-G in muscles fibers. 
(A) The tibialis anterior of 12 day-old rats was in vivo injected with cDNA constructs encoding 
the GFP-tagged small muscle isoforms of ankyrin-G. Ten days later the recombinant 
polypeptides (AnkG107, AnkG109, AnkG128, and AnkG130) were immunolocalized in muscle 
cryosections by confocal microscopy using anti-GFP antibodies (green). Sections were double 
labeled with anti-αII spectrin antibodies (red). All muscle isoforms colocalized with spectrin at 
the sarcolemma. In control experiments, the lack of the 76aa (AnkG107∆76aa) resulted in greatly 
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enhanced cytoplasmic distribution. The green fluorescent protein alone (GFP) remained 
cytoplasmic.  
(B) Costameric distribution of muscle ankyrins-G. Confocal superficial optical sections of muscle 
fibers expressing GFP-tagged AnkG107 show a rectilinear costameric pattern of labeling (green, 
anti-GFP) and partial colocalization of the muscle ankyrin-G with spectrin (red, anti-αII spectrin) 
at the sarcolemma. Bars: 10 µm.   
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 Table 1  
 Nucleotide sequences of primers  
 Primer  Sequence (5'→3')  Orientation  
   
 gt1  AGCAAGTCCAGCCTGGTTAAGT  forward  
 gt2  CTTATGAGTATTTCTTCCAGGGTA  reverse  
 5’UTRmb-ne1  TATCTTGGGGTAATGACTTGCTGACA  forward  
 5’UTRmb-ne2  TCTTTGTCGGGGGTTTGGATGTG  forward  
 13/2-1R   CCGGTGGCACAGGTGTCGTTGTT  reverse  
 3’UTRn2  AAAAACCCAAAACCCCAAACATG  reverse  
 5’Malpa   AAAGCATTCCTCAACCCAGCGTG  forward  
 Malpan2  CAGCGTGGTGGAAATGGCTTTG  forward  
 5’RACEn3  GGCACCATTGTCCAGAAGAAACCT  reverse  
 5’RACEn4  AGACCTTGACCACTTCCGCTTGT  reverse  
 3’Malpa  GCATCTTCACTGTGTGGCAAAGC  reverse  
 3’Malpan2  CACGCTGGGTTGAGGAATGCTTT  reverse  
 9/3-1  CGGGAAGAATGCCACAACTGATG  forward  
 17Aup  GGATGACCGCCTGCTGTTACAAG  forward  
 9/3-2  ACGAGACGCCAAGTGGAAGCCTA  forward  
 e24u  GCCATCACAGGGGACACTGACAA  forward  
 e26r1  GCTCCTCGATCATCATGCTGTCC  reverse  
 e8up  ATCCCGATTCTGTCAGCCATTTCT  reverse  
 e8lo  ACCATATTTGCGTTTCCCCGTTTC  forward  
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